Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Sharon Gardner"'
Autor:
Girish Dhall, Ira J. Dunkel, Mohammad H Abu-Arja, Jason Fangusaro, Tom B. Davidson, Sharon Gardner, Jonathan L. Finlay, Joseph Stanek, Mohamed S. AbdelBaki
Publikováno v:
Pediatr Blood Cancer
Background We report the outcomes of patients with pineoblastoma and trilateral retinoblastoma syndrome enrolled on the Head Start (HS) I-III trials. Methods Twenty-three children were enrolled prospectively between 1991 and 2009. Treatment included
Autor:
Laura Vasquez, C Altshuler, Sharon Gardner, Joseph Stanek, Girish Dhall, Jonathan L. Finlay, Kelley Haley
Publikováno v:
Bone Marrow Transplantation. 51:945-948
Since 1991, three sequential prospective clinical trials have been conducted by the 'Head Start' (HS) Consortium in which young children with newly-diagnosed malignant central nervous system (CNS) tumors were treated with induction chemotherapy follo
Autor:
Sharon Gardner, Jeffrey C. Allen, Andrea Cappellano, Clara Belessiotis, Nicholas G. Gottardo, Nasjla S. DaSilva, Mark Weinblatt, Jonathan L. Finlay, Girish Dhall, Blanca Diez, Rachel Pruitt
Publikováno v:
Pediatric Blood & Cancer. 62:1920-1924
Objectives To evaluate patterns of relapse and outcome in patients newly diagnosed with CNS Mixed Malignant GCT (MMGCT) treated initially with chemotherapy alone. Methods A retrospective chart review was conducted using all 25 patients enrolled on th
Autor:
Elizabeth A. Raetz, Rakesh K. Goyal, Julie M. Gastier-Foster, Michael A. Pulsipher, Bryan Langholz, Kirk R. Schultz, Sharon Gardner, Michael J. Borowitz, David T. Teachey, Stephan A. Grupp, Nancy Bunin, William L. Carroll, Donna A. Wall
Publikováno v:
Bone Marrow Transplantation. 50:1173-1179
We previously showed that minimal residual disease (MRD) detection pre-hematopoietic cell transplant (HCT) and acute GvHD (aGvHD) independently predicted risk of relapse in pediatric ALL. In this study we further define risk by assessing timing of re
Autor:
Vedat O. Yildiz, Maxim Yankelevich, Girish Dhall, Soumen Khatua, Sharon Gardner, Jonathan L. Finlay, Kevin Ginn, Robert J. Brown, Wafik Zaky
Publikováno v:
Pediatric Blood & Cancer. 62:784-789
Background Choroid plexus carcinoma (CPC) is a rare aggressive intracranial neoplasm with a predilection for young children and a historically poor outcome. Currently, no defined optimal therapeutic strategy exists. The Head Start (HS) regimens have
Autor:
Kelly Ann Cervone, Jonathan L. Finlay, Sharon Gardner, Rakesh K. Goyal, K. M. Steve Lo, Diana S Osorio, Ira J. Dunkel
Publikováno v:
Pediatric bloodcancer. 65(1)
BACKGROUND: The purpose of this study was to determine the feasibility and tolerability of tandem courses of high-dose thiotepa with autologous hematopoietic cell rescue (AHCR) in patients with recurrent, refractory solid tumors who were ineligible f
Autor:
Stephen A. Sands, Christina G. Salley, Juliette Hukin, Judith D. Goldberg, Sharon Gardner, Aniket Saha, Jonathan L. Finlay, Suzanne Scott, Randal Olshefski, Linda Rolnitzky, Preeti Saigal
Publikováno v:
Pediatric Blood & Cancer. 61:1644-1672
Background Due to the devastating late effects associated with cranial irradiation in young children with central nervous system (CNS) tumors, treatment for these patients has evolved to include the use of intensive chemotherapy to either avoid or po
Autor:
Julie M. Gastier-Foster, Michael J. Borowitz, James G. Douglas, Elizabeth A. Raetz, Kirk R. Schultz, William L. Carroll, Donna A. Wall, Y. Barnes, Denise L. Howrie, Michael A. Pulsipher, Candace Taylor, Sharon Gardner, Bryan Langholz, David T. Teachey, Stephan A. Grupp, Rakesh K. Goyal, Nancy Bunin
Publikováno v:
Blood. 123:2017-2025
Sirolimus has activity against acute lymphoblastic leukemia (ALL) in xenograft models and efficacy in preventing acute graft-versus-host disease (aGVHD). We tested whether addition of sirolimus to GVHD prophylaxis of children with ALL would decrease
Autor:
Sharon Gardner, Anat Erdreich-Epstein, Reuben Antony, Moneil Patel, Girish Dhall, Jonathan L. Finlay, Gordon McComb, Mark D. Krieger, Kenneth E. Wong, Floyd H. Gilles, Arthur J. Olch, Richard Sposto
Publikováno v:
Pediatric Blood & Cancer. 61:1195-1201
Background Recurrence occurs in almost 50% of patients with intracranial ependymoma, and their outcome following recurrence is poor. Methods We retrospectively reviewed the medical records of 22 patients with intracranial ependymoma and subsequent re
Autor:
Girish Dhall, Joseph Torkildson, Kamnesh R. Pradhan, Richard Sposto, Lingyun Ji, Salvatore Bertolone, Jonathan L. Finlay, Stephen Thompson, Ramesh Patel, Mark Atlas, Sharon Gardner, Violet Shen, Wafik Zaky, Jeffrey C. Allen, Kelley Haley, Albert Cornelius
Publikováno v:
Pediatric Blood & Cancer. 61:95-101
Background Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is a rare embryonal neoplasm of early childhood with dismal outcome and no current uniformly accepted treatment. Given its highly aggressive nature and predilecti